Hale Therapeutics Overview

  • Founded
  • 2017

Founded
  • Status
  • Private

  • Employees
  • 39

Employees
  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $26.5K

  • Investors
  • 24

Hale Therapeutics General Information

Description

Developer of a vaporizer system designed to help people battling nicotine addiction. The company's system is designed with a comfortable mouthpiece, two-sided grips for comfort, a light-emitting diode (LED) Indicator for battery life, and companion applications to track usage, enabling users to lower their nicotine addiction.

Contact Information

Website
www.tryhale.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 2025 Washington Avenue
  • Suite 216
  • Philadelphia, PA 19146
  • United States
+1 (609) 000-0000

Hale Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hale Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Equity Crowdfunding 13-Jul-2022 $26.5K 00.000 Completed Product Development
9. Accelerator/Incubator 06-Dec-2021 00.000 Completed Product Development
8. Seed Round 10-Nov-2021 000 00.000 Completed Product Development
7. Accelerator/Incubator 04-Nov-2021 00.000 Completed Product Development
6. Early Stage VC (Series 1) 01-Dec-2020 00.000 Completed Product Development
5. Grant 24-Jun-2020 0000 00.000 Completed Product Development
4. Early Stage VC 13-Nov-2019 00.00 00.000 Completed Startup
3. Accelerator/Incubator 01-Apr-2019 00000 00000 Completed Startup
2. Accelerator/Incubator 15-Mar-2019 $100K $125K 000 Completed Startup
1. Accelerator/Incubator 01-Jul-2018 $25K $25K Completed Startup
To view Hale Therapeutics’s complete valuation and funding history, request access »

Hale Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a vaporizer system designed to help people battling nicotine addiction. The company's system is designed wi
Therapeutic Devices
Philadelphia, PA
39 As of 2021
00.000
000000000000 00.000

0000 0

veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
00000 0000000000 0000000000 0000000
New York, NY
000 As of 0000
000.00
0000 0000-00-00
00000000000 000.00

0000

t aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse ci
0000 00000000
Los Angeles, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hale Therapeutics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Quit Genius Venture Capital-Backed New York, NY 000 000.00 00000000000 000.00
0000 Venture Capital-Backed Los Angeles, CA 00 000.00 00000000000 000.00
000000000000000 00 Corporate Backed or Acquired Gurgaon, India 0000 000000&0
0000000 & 0000000 Corporation Neenah, WI 000000 00000000
000000 Corporation New York, NY 00000 000000000-00
You’re viewing 5 of 5 competitors. Get the full list »

Hale Therapeutics Patents

Hale Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200229512-A1 Vaporization device Inactive 18-Jan-2019 0000000000
GB-202111012-D0 Vaporization device Pending 18-Jan-2019 000000000
GB-2595107-A Vaporization device Pending 18-Jan-2019 000000000
US-20200229508-A1 Vaporization device Pending 18-Jan-2019 000000000 00
US-20220248767-A1 Smoking cessation system Pending 18-Jan-2019 A24F40/65
To view Hale Therapeutics’s complete patent history, request access »

Hale Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Josh Israel Co-Founder, Chief Executive Officer & Board Member
Devin Serago Co-Founder & Chief Operating Officer
Patrick Bursch Biomechanical Engineer
Jeff Domenighini Head of Mechanical Engineering
Predrag Markovic Head of Product Design
You’re viewing 5 of 7 executive team members. Get the full list »

Hale Therapeutics Board Members (1)

Name Representing Role Since
Josh Israel Hale Therapeutics Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Hale Therapeutics’s complete board members history, request access »

Hale Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hale Therapeutics Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AlphaLab Health Accelerator/Incubator Minority 000 0000 000000 0
Atland Ventures Venture Capital Minority 000 0000 000000 0
Innovation Works Venture Capital Minority 000 0000 000000 0
PACT Incubator Accelerator/Incubator 000 0000 000000 0
Benjamin Stein Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »